tiprankstipranks
Advertisement
Advertisement

XTLB Stock Latest News

XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
Company AnnouncementsXTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
27d ago
6K
XTLB
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
PremiumCompany Announcements
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
1M ago
6K
XTLB
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
PremiumCompany Announcements
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
1M ago
6K
XTLB
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
PremiumCompany Announcements
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
2M ago
XTLB
3 Penny Stocks to Watch Now, 4/30/26
PremiumMarket News
3 Penny Stocks to Watch Now, 4/30/26
2M ago
AKAN
RDAC
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline
PremiumCompany AnnouncementsXTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline
2M ago
6K
XTLB
XTL Biopharmaceuticals to acquire Psyga Bio
Premium
The Fly
XTL Biopharmaceuticals to acquire Psyga Bio
2M ago
XTLB
XTL Biopharmaceuticals trading halted, news pending
Premium
The Fly
XTL Biopharmaceuticals trading halted, news pending
3M ago
XTLB
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
3M ago
AZI
JFB
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
PremiumCompany Announcements
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
3M ago
6K
XTLB
XTL Biopharmaceuticals announces ADS ratio change
PremiumThe Fly
XTL Biopharmaceuticals announces ADS ratio change
3M ago
XTLB
XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires
PremiumCompany Announcements
XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires
3M ago
6K
XTLB
Beyond Air announces termination of NeuroNOS agreement with XTL
PremiumThe FlyBeyond Air announces termination of NeuroNOS agreement with XTL
3M ago
XAIR
XTLB
XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination
Premium
Company Announcements
XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination
4M ago
6K
XTLB
XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing
Premium
The Fly
XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing
4M ago
XTLB
XTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement
PremiumCompany Announcements
XTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement
4M ago
6K
XTLB
XTL Biopharmaceuticals Faces Liquidation of Web Data Subsidiary After Insolvency Ruling
PremiumCompany Announcements
XTL Biopharmaceuticals Faces Liquidation of Web Data Subsidiary After Insolvency Ruling
4M ago
6K
XTLB
XTL Biopharmaceuticals Adjourns Extraordinary Shareholders Meeting for Lack of Quorum
PremiumCompany Announcements
XTL Biopharmaceuticals Adjourns Extraordinary Shareholders Meeting for Lack of Quorum
4M ago
6K
XTLB
XTL Biopharmaceuticals provides update on recent developments
PremiumThe Fly
XTL Biopharmaceuticals provides update on recent developments
5M ago
XAIR
XTLB
XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency
PremiumCompany AnnouncementsXTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency
5M ago
6K
XTLB
XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure
Premium
Company Announcements
XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure
5M ago
6K
XTLB
XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance
Premium
Company Announcements
XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance
5M ago
6K
XTLB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >